Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114669 · ClinicalTrials.gov registry record · NA
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 401
- Enrollment target
NCT04114669 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 401 participants.
The verdict
NCT04114669, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 401 participants
- Enrollment target
Study Summary
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H ambulatory clinics as well as NYU Langone Family Health Centers, and will use a lottery incentive program to promote adherence to antihypertensive medication that will be delivered via smartphone for 6 months. The trial will randomize 435 patients with hypertension determined to have poor adherence (\<80% adherence with antihypertensive medication), in a 2:1 (intervention:control) ratio. Baseline enrollment will occur over 36 months with an expected 12 months follow-up per participant.
Interventions
- BEHAVIORAL Control Condition
- BEHAVIORAL Regret Lottery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2025-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04114669
The ClinicalTrials.gov registry entry for NCT04114669 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.
NCT04114669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04114669 about?
NCT04114669 is a clinical study titled "Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)". BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H am...
What is the current status of trial NCT04114669?
This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 2020-07-14. Estimated completion is 2025-09-12.
What interventions are being tested in trial NCT04114669?
The interventions under investigation include: Control Condition (BEHAVIORAL), Regret Lottery (BEHAVIORAL).
Who is sponsoring clinical trial NCT04114669?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.